Practices


Reputation, Revenue at Risk

November 5, 2004 - Already wounded by the withdrawal of its Vioxx pain reliever from the market, Merck & Co. must now contend with hundreds of lawsuits over the drug's side effects. Read More


Lawyers Organizing for Mass Suits Over Vioxx

November 5, 2004 - Hundreds of plaintiffs' lawyers who claim that people were injured or killed by the Read More


Liablity could Reach $17.6B

November 5, 2004 - Already wounded by the withdrawal of its Vioxx pain reliever from the market, Merck & Co. must now contend with hundreds of lawsuits over the drug's side effects. Read More


Vioxx battles could cost Merck up to $18B

November 5, 2004 - Already wounded by the withdrawal of its Vioxx pain reliever from the market, Merck must now contend with hundreds of lawsuits over the drug's side effects. Read More


Lawyers Organizing for Mass Lawsuits over Vioxx

November 5, 2004 - Hundreds of plaintiffs' lawyers who claim that people were injured or killed by the painkiller Vioxx plan to meet next week to lay the groundwork for a nationwide legal assault against the... Read More


Merck Faces Slew Of Vioxx Lawsuits

November 5, 2004 - Already wounded by the withdrawal of its Vioxx pain reliever from the market, Merck & Co. must now contend with hundreds of lawsuits over the drug's side effects. Read More


Merck Faces Slew of Vioxx Suits

November 5, 2004 - Already wounded by the withdrawal of its Vioxx pain reliever from the market, Merck & Co. must now contend with hundreds of lawsuits over the drug's side effects - lawsuits that... Read More


Merck Faces Huge Fallout Over Vioxx Suits

November 4, 2004 - Already wounded by the withdrawal of its Vioxx pain reliever from the market, Merck & Co. must now contend with hundreds of lawsuits over the drug's side effects - lawsuits that... Read More


Merck Falls on report of Secrecy

November 2, 2004 - Shares of Merck & Co. plunged again after a news report suggested the drug maker attempted to keep safety worries from hurting the prospects of Vioxx before the company finally recalled the... Read More


News that maker hid Vioxx data sinks stock 10 percent

November 2, 2004 - Shares of Merck & Co. plunged more than 10 percent yesterday after a news report said documents showed the pharmaceutical giant hid or denied evidence for years that its blockbuster... Read More


back to top